Croop R, Madonia J, Stock DA, Thiry A, et al. Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double-blind, randomized, placebo-controlled, dose-ranging trial. Headache 2022 Oct 14. doi: 10.1111/head.14389.
PMID: 36239038